Four genetic syndromes associated with arteriovenous malformations: an overview

Abstract

Abstract: Arteriovenous malformations (AVMs), are the most dangerous type of vascular malformations, which may occurred as one of the performance of certain genetic syndromes, found in various parts of the body. In this review, we focused on arteriovenous malformation related with genetic syndromes and their clinical manifestation, pathogenesis, diagnosis and therapeutic strategies were discussed, including hereditary hemorrhagictelangiectasia, capillary malformation-arteriovenous malformation, Parkes-Weber syndrome and Cobb syndrome.

Key words: Arteriovenous malformation, Hereditary hemorrhagictelangiectasia, Capillary malformation-arteriovenous malformation, Parkes-Weber syndrome, Cobb syndrome

HUANG Zi-xian, HUANG Zhi-quan. Four genetic syndromes associated with arteriovenous malformations: an overview[J]. Shanghai Journal of Stomatology, 2015, 24(5): 470-473.

References

[1] Kohout MP, Hansen M, Pribaz JJ, et al. Arteriovenous malformations of the head and neck: natural history and management [J]. Plast Reconstr Surg, 1998, 102(3): 643-654.
[2] 中华口腔医学会口腔颌面外科专业委员会脉管性疾病学组. 口腔颌面部动静脉畸形诊治指南[J]. 中国口腔颌面外科杂志, 2011, 9(3):242-247.
[3] Tille JC, Pepper MS. Hereditary vascular anomalies: new insights into their pathogenesis [J]. Arterioscler Thromb Vasc Biol, 2004, 24(9): 1578-1590.
[4] Meyer M, Barsness KA. Umbilical arteriovenous malformation: a case report and literature review [J]. Pediatr Surg Int, 2013, 29(8): 851-853.
[5] Mcdonald MT, Papenberg KA, Ghosh S, et al. A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34 [J]. Nat Genet, 1994, 6(2): 197-204.
[6] Berg JN, Gallione CJ, Stenzel TT, et al. The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2[J]. Am J Hum Genet,1997,61(1): 60-67.
[7] Draghi F, Presazzi A, Danesino GM, et al. Hepatic sonography in patients with hereditary hemorrhagic telangiectasia hospitalized for epistaxis [J]. J Ultrasound, 2012, 15(3): 164-170.
[8] Faughnan ME, Palda VA, Garcia-Tsao G, et al. International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia[J]. J Med Genet, 2011, 48(2): 73-87.
[9] Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome) [J]. Am J Med Genet, 2000, 91(1): 66-67.
[10] Bailly S, Dupuis-Girod S, Plauchu H. Rendu-Osler disease: clinical and molecular update [J]. Med Sci (Paris), 2010, 26(10): 855-860.
[11] Eerola I, Boon LM, Mulliken JB, et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations [J]. Am J Hum Genet, 2003, 73(6): 1240-1249.
[12] de Wijn RS, Oduber CE, Breugem CC, et al. Phenotypic variability in a family with capillary malformations caused by a mutation in the RASA1 gene [J]. Eur J Med Genet, 2012, 55(3): 191-195.
[13] Revencu N, Boon LM, Mendola A, et al. RASA1 mutations and associated phenotypes in 68 families with capillary malformation-arteriovenous malformation [J]. Hum Mutat, 2013, 34(12): 1632-1641.
[14] Serban D, Leng J, Cheresh D. H-ras regulates angiogenesis and vascular permeability by activation of distinct downstream effectors [J]. Circ Res,2008, 102(11): 1350-1358.
[15] Thiex R, Mulliken JB, Revencu N, et al. A novel association between RASA1 mutations and spinal arteriovenous anomalies [J]. AJNR Am J Neuroradiol, 2010, 31(4): 775-779.
[16] Larralde M, Abad ME, Luna PC, et al. Capillary malformation-arteriovenous malformation: a clinical review of 45 patients [J]. Int J Dermatol, 2014, 53(4): 458-461.
[17] Orme CM, Boyden LM, Choate KA, et al. Capillary malformation—arteriovenous malformation syndrome: review of the literature, proposed diagnostic criteria, and recommendations for management [J]. Pediatr Dermatol, 2013, 30(4): 409-415.
[18] Walcott BP, Smith ER, Scott RM, et al. Pial arteriovenous fistulae in pediatric patients: associated syndromes and treatment outcome [J]. J Neurointerv Surg, 2013, 5(1): 10-14.
[19] Bartels C, Claeys L, Ktenidis K, et al. F.P. Weber syndrome associated with a brachial artery aneurysm. A case report [J]. Angiology, 1995, 46(11): 1039-1042.
[20] Lehmann TG, Düx M, von Herbay A, et al. Klippel-Trénaunay syndrome with involvement of the rectum. Surgical therapy after interventional-radiologic preparation [J]. Chirurg, 2000, 71(2): 228-233.
[21] Hallett KB, Bankier A, Chow CW, et al. Gingival fibromatosis and Klippel-Trénaunay-Weber syndrome. Case report [J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod,1995,79(5):578-582.
[22] Whelan AJ, Watson MS, Porter FD, et al. Klippel-Trenaunay-Weber syndrome associated with a 5:11 balanced translocation [J]. Am J Med Genet, 1995, 59(4): 492-494.
[23] Gir&#x0dbc0;&#x0dda9;n-Vallejo O, L&#x0dbc0;&#x0dda9;pez-Gutiérrez JC, Fern&#x0dbc0;&#x0dda6;ndez-Pineda I. Diagnosis and treatment of Parkes Weber syndrome: a review of 10 consecutive patients[J]. Ann Vasc Surg, 2013, 27(6): 820-825.
[24] Meijer-Jorna LB, Breugem CC, de Boer OJ, et al. Presence of a distinct neural component in congenital vascular malformations relates to the histological type and location of the lesion [J]. Hum Pathol, 2009, 40(10): 1467-1473.
[25] Revencu N, Boon LM, Mulliken JB, et al. Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused by RASA1 mutations [J]. Hum Mutat, 2008, 29(7): 959-965.
[26] Yang X, Peterson L, Thieringer R, et al. Identification and validation of genes affecting aortic lesions in mice [J]. J Clin Invest, 2010, 120(7): 2414-2422.
[27] Prakash S, Lemaire SA, Bray M, et al. Large deletions and uniparental disomy detected by SNP arrays in adults with thoracic aortic aneurysms and dissections [J]. Am J Med Genet A, 2010, 152A(9): 2399-2405.
[28] Lebrin F, Srun S, Raymond K, et al. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia [J]. Nat Med, 2010, 16(4): 420-428.
[29] Burrows PE, Mulliken JB, Fishman SJ, et al. Pharmacological treatment of a diffuse arteriovenous malformation of the upper extremity in a child [J]. J Craniofac Surg, 2009, 20(Suppl 1): 597-602.
[30] Clark MT, Brooks EL, Chong W, et al. Cobb syndrome: a case report and systematic review of the literature [J]. Pediatr Neurol, 2008, 39(6): 423-425.
[31] Matsui Y, Mineharu Y, Satow T, et al. Coexistence of multiple cavernous angiomas in the spinal cord and skin: a unique case of Cobb syndrome [J]. J Neurosurg Spine, 2014, 20(2): 142-147.
[32] Maramattom BV, Cohen-Gadol AA, Wijdicks EF, et al. Segmental cutaneous hemangioma and spinal arteriovenous malformation (Cobb syndrome). Case report and historical perspective [J]. J Neurosurg Spine, 2005, 3(3): 249-252.
[33] Schirmer CM, Hwang SW, Riesenburger RI, et al. Obliteration of a metameric spinal arteriovenous malformation (Cobb syndrome) using combined endovascular embolization and surgical excision [J]. J Neurosurg Pediatr, 2012, 10(1): 44-49.
[34] Bao YH, Ling F. Classification and therapeutic modalities of spinal vascular malformations in 80 patients [J]. Neurosurgery, 1997, 40(1): 75-81.
[35] Wetter DA, Davis MD, Hand JL. Acute paralysis in a 17-year-old man with subtle cutaneous vascular malformations: an unusual case of Cobb syndrome[J]. J Eur Acad Dermatol Venereol, 2008, 22(4): 525-526.